Goldman Sachs: The CG Oncology (CGON.US) rating was raised from neutral to buy, and the target price was $50.00.
高盛：上调CG Oncology(CGON.US)评级，由中性调整至买入评级, 目标价50.00美元。
Goldman Sachs: The CG Oncology (CGON.US) rating was raised from neutral to buy, and the target price was $50.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.